The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection
Open accessAbstract
We propose that a novel mechanism of hepatocyte apoptosis, involving a cooperative interaction between CD40 and Fas, is involved in the hepatocyte loss of chronic liver allograft rejection. We detected increased hepatocyte expression of Fas, Fas ligand (FasL), and CD40 associated with dropout of centrilobular (acinar zone 3) hepatocytes in chronic allograft rejection. Expression of CD40 ligand (CD40L) was also increased but was largely restricted to CD68+ macrophages. A functional role for CD40 and Fas in hepatocyte apoptosis was demonstrated in vitro using primary human hepatocytes and the HepG2 cell line in both of which apoptosis was induced, not only by cross-linking Fas directly but also via CD40 activation. Our data suggest that CD40 activation induces apoptosis via Fas because (a) ligation of CD40 upregulated hepatocyte FasL expression, and (b) apoptosis induced via activation of CD40 was prevented by a neutralizing monoclonal antibody to FasL. Thus, CD40 engagement triggers apoptosis of human hepatocytes and might amplify Fas-dependent hepatocyte apoptosis in chronic rejection and other inflammatory liver diseases in which Fas-mediated apoptosis is involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Cited by
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
Oxidative Stress in Liver Pathophysiology and Disease
Allameh, A., Niayesh-Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 514
Vonderheide, R. H., Flaherty, K. T., Khalil, M., Stumacher, M. S., Bajor, D. L., Hutnick, N. A., Sullivan, P., Mahany, J. J., Gallagher, M., Kramer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3311 · Cited by 513
Role of Kupffer cells in the pathogenesis of liver disease
Kolios, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7413 · Cited by 505
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Self-citationInhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Grant, A. J., Lalor, P. F., Hübscher, S. G., Briskin, M., & Adams, D. H. (2001) · Hepatology · doi:10.1053/jhep.2001.24231 · Cited by 297
Self-citationGrell, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3034 · Cited by 284
Kovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., & Taub, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100740200 · Cited by 280
Zhang, H., Cook, J., Nickel, J., Yu, R., Stecker, K., Myers, K., & Dean, N. M. (2000) · Nature Biotechnology · doi:10.1038/78475 · Cited by 268
Oxidative Stress and the Homeodynamics of Iron Metabolism
Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5020808 · Cited by 247
“However, different from the yeast Ftx knock-out mutant Yfh1 [245] and Ftx-deleted mammalian cells, mitochondrial iron deposits have neither been found in FRDA patients [246] nor in Ftx-deficient Prp-CreERT mice [247].”
BackgroundJeffery, H. C., van Wilgenburg, B., Kurioka, A., Parekh, K., Stirling, K., Roberts, S., Dutton, E. E., Hunter, S., Geh, D., Braitch, M. K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.017 · Cited by 212
Self-citationSchwabe, R. F., Schnabl, B., Kweon, Y. O., & Brenner, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6812 · Cited by 155
“Hepatocytes and sinusoidal endothelial cells showed weaker staining for CD40, confirming data from previous studies demonstrating that these cell populations express CD40 under inflammatory conditions such as chronic rejection and acute liver failure, respectively (13, 25).”
BackgroundResultMortality from cirrhosis: lack of progress over the last 35 years
Gluud, C. (2005) · Gut · doi:10.1136/gut.2005.072876 · Cited by 17
Jung, S., Singh, K., & del Sol, A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa283 · Cited by 9
“On the contrary, previous studies suggested that the functional hepatocyte state characterized by active Cd40 signaling likely amplifies Fas-dependent apoptosis, thus contributing to the progressive formation of scar tissue in response to injury [58].”
Metadata
- Authors
- Afford, S. C., Randhawa, S., Eliopoulos, A. G., Hubscher, S. G., Young, L. S., & Adams, D. H.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-01-18
- Volume
- 189
- Issue
- 2
- Pages
- 441-446
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2004071897
- Cited by
- 192
- References
- 2
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.